C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2001
10/24/2001	CN1319105A Methods for produsction of antibodies to specific regions of cyclosporine and cyclosporine metabolites
10/24/2001	CN1073626C Productive technology for A-type botulism crystalline toxin and frozen-dried protective liquid needed for producing said toxin
10/23/2001	US6307030 Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions
10/23/2001	US6307024 Polypeptides; for use in the proliferation of hematopoietic cells
10/23/2001	US6307022 Def
10/23/2001	US6307021 Polypeptide; for use in the treatment of defects associated with amplified or decreased apoptosis
10/23/2001	US6306654 Nucleotide sequence coding mutant gonadotrophin hormone; for treatment of reproduction defects
10/23/2001	US6306648 Amino acid sequences for use as enzyme inhibitors; for use in preventing and treatment of oncogenesis; antitumor agents
10/23/2001	US6306637 Production of virus and purification of viral envelope proteins for vaccine use
10/23/2001	US6306628 Methods for the detection, analysis and isolation of Nascent proteins
10/23/2001	US6306624 Retinoid metabolizing protein
10/23/2001	US6306622 cDNA encoding a BMP type II receptor
10/23/2001	US6306608 Anti-human LECT2 antibody, cells producing the same, and method and kit for assaying the same
10/23/2001	US6306605 Methods for making recombinant cells
10/23/2001	US6306600 Analyzing transcriptional or translational regulatory sequences by transfecting cells with expression vector encoding green fluorescent protein linked to pest sequence, then detecting fluorescence in cells compared to controls
10/23/2001	US6306583 Human brain phosphodiesterase
10/23/2001	US6306581 Diagnostic assay method and kit for the detection of HHV-8 infection
10/23/2001	US6306579 Immunoassay by incubating sample with at least one peptide from ns3 region having at least one covalently modified cysteine or replaced cysteine, then determining binding of antibody to peptide
10/23/2001	US6306402 Compounds and methods for the diagnosis and treatment of EHRLICHIA infection
10/23/2001	US6306401 Genetically-engineered sindbis virus with modified E2 Glycoprotein and altered host-range phenotype
10/23/2001	US6306397 Variants of human papilloma virus antigens
10/23/2001	US6306396 Compounds and methods for the diagnosis and treatment of B. microti infection
10/23/2001	CA1341308C Vaccines against avian herpes viruses
10/23/2001	CA1341307C Nucleotide sequences of avian herpes viruses
10/18/2001	WO2001077389A2 Genes expressed in foam cell differentiation
10/18/2001	WO2001077362A1 Immunoassay of anti-hm1.24 antibody
10/18/2001	WO2001077360A2 Methods for ansamitocin production
10/18/2001	WO2001077342A1 Multivalent antibodies and uses therefor
10/18/2001	WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses
10/18/2001	WO2001077323A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof
10/18/2001	WO2001077322A1 Cryptic-like secreted protein
10/18/2001	WO2001077321A2 Identification of a human gaba transporter
10/18/2001	WO2001077181A2 Anti-rhesus d monoclonal antibodies
10/18/2001	WO2001077179A1 Proteins with a high immunoreactivity and a method for the production thereof
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	WO2001077158A1 Hepatitis b core antigen fusion proteins
10/18/2001	WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001	WO2001077148A2 Human lipid binding protein 1
10/18/2001	WO2001076391A1 Cultured protein hydrolysate
10/18/2001	WO2001038548A3 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/18/2001	WO2001036626A3 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
10/18/2001	WO2001027613A3 Improved method for the detection of acid resistant microorganisms in a stool
10/18/2001	WO2001026608A3 Dna vaccines encoding antigen linked to a domain that binds cd40
10/18/2001	WO2001025430A3 Novel human membrane proteins
10/18/2001	WO2001023540A3 P-glycoproteins and uses thereof
10/18/2001	WO2000073460A3 Modified cytokine for its stabilisation
10/18/2001	WO2000046236A9 Novel rgs-containing molecules and uses thereof
10/18/2001	US20010031860 Serum marker, immunohistological marker to detect prostate cancer tissues
10/18/2001	US20010031859 Human cell line characterized by expression of code sequence for antiapoptotic protein and level of cytokine production twice that of of cytokine production exhibited by parental cell line that does not express code for antiapoptotic protein
10/18/2001	US20010031857 Memno peptides, process for their preparation and use thereof
10/18/2001	US20010031740 Mixture containing organic halide
10/18/2001	US20010031476 Determining rate of bone resorption by measuring peptides in body fluid having 3-hydroxypyridinium cross-link; diagnostic tool for Paget's disease
10/18/2001	US20010031463 Using an antibody linked to an activated chromatographic material, applying a sample containing Adeno-associated type 2 viruses (AAV-2), and eluting with a solution containing magnesium chloride
10/18/2001	US20010031261 Use of genetically engineered antibodies to treat multiple myeloma
10/18/2001	US20010031259 Novel methods and compositions for treatment of autoimmune diseases
10/18/2001	DE10016877A1 (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung (Glyco) proteins with high immunoreactivity, and a method for their preparation
10/18/2001	DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system
10/18/2001	CA2406448A1 Identification of a human gaba transporter
10/18/2001	CA2406188A1 Methods for ansamitocin production
10/18/2001	CA2406033A1 Anti-d monoclonal antibodies
10/18/2001	CA2405800A1 Novel secreted protein
10/18/2001	CA2405124A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof
10/18/2001	CA2405104A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	CA2404988A1 Listeria monocytogenes genome, polypeptides and uses
10/18/2001	CA2404779A1 Human lipid binding protein 1
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2403946A1 Genes expressed in foam cell differentiation
10/18/2001	CA2403425A1 Multivalent antibodies and uses therefor
10/18/2001	CA2343602A1 Est's and encoded human proteins
10/17/2001	EP1146124A2 Gustducin materials and methods
10/17/2001	EP1146121A1 Method for modification of proteins by transglutaminase
10/17/2001	EP1146056A1 Antibodies which activate an erythropoietin receptor
10/17/2001	EP1146054A1 ReL1A BINDING INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
10/17/2001	EP1144998A2 Neisseria genomic sequences and methods of their use
10/17/2001	EP1144658A2 Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells
10/17/2001	EP1144655A2 Regulated expression using conditional er retention domains
10/17/2001	EP1144650A2 Goodpasture antigen binding protein
10/17/2001	EP1144644A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
10/17/2001	EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/17/2001	EP1144634A2 Novel complex-forming proteins
10/17/2001	EP1144633A1 Polypeptide
10/17/2001	EP1144630A2 Human cell signaling proteins (csig)
10/17/2001	EP1144628A2 Human vanilloid receptor gene
10/17/2001	EP1144626A2 Methods of monitoring hiv drug resistance
10/17/2001	EP1144625A2 Nucleic-acid binding proteins
10/17/2001	EP1144617A2 Cancer-associated proteins
10/17/2001	EP1144616A1 Method for producing antibody fragments
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144613A1 Methods for making proteins containing free cysteine residues
10/17/2001	EP1144611A2 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin
10/17/2001	EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001	EP1144590A1 Compartmentalization of recombinant polypeptides in host cells
10/17/2001	EP1144587A1 Device for carrying out the cell-free synthesis of proteins
10/17/2001	EP1144454A2 Modified peptides as therapeutic agents
10/17/2001	EP1144453A1 Anti-ccr4 antibodies and methods of use therefor
10/17/2001	EP1144449A1 Reagents and methods useful for detecting diseases of the breast
10/17/2001	EP1144448A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
10/17/2001	EP1144444A2 Dnas encoding proteins with signal sequences
10/17/2001	EP1144443A2 Human membrane transport proteins

1 ... 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 ... 1125